NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2017, Vol. 29 ›› Issue (10): 1723-1727.doi: 10.16333/j.1001-6880.2017.10.016

• Article • Previous Articles     Next Articles

Protective Effect of Rosemarinic Acid on MPTP Induced Dopaminergic Neurons Toxicity

ZHONG Wen-wen1,2; ZHANG Zhi-bi2; ZHANG Lan-chun1; YU Hao-fei1,2; ZHANG Rong-ping1,2*; HU Wei-yan1*   

  1. 1School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University; 2Biomedical Engineering Research center of Kunming Medical University,Kunming 650500, China
  • Online:2017-10-27 Published:2017-10-27

Abstract: Dopaminergic neurons injury is a key pathogenic factor at the onset of Parkinson’s disease.To investigate the protective effect and possible mechanisms of rosemarinic acid (RA) on MPTP induced dopaminergic neurons injury,dopaminergic neurons were pretreated with rosemarinic acid for 30 min prior to MPTP treatment,neuron viability,ROS lever,caspase-3 lever and cleaved caspase-3 level were measured.Results showed that MPTP induced dopaminergic neuron viability decreased (P<0.05),ROS level and cleaved caspase-3 level increased (P<0.01).Moreover,the application of RA (40 μmol/L and 20 μmol/L) can effectively reverse MPTP induced dopaminergic neuron viability decrease,ROS level and cleaved caspase-3 level increase (P<0.05,P<0.01).These results indicated that rosemarinic acid can protect MPTP induced dopaminergic neuron toxicity possibly through decreasing aberrant elevation of ROS and reverse abnormal aspase-3 activity.

Key words: rosemarinic acid, MPTP, ROS, Caspase-3, Parkinson’s disease

CLC Number: